Stavudine (d4T) , ≥98% , 3056-17-5
Synonym(s):
Stavudine;d4T;1-(2,3-Dideoxy-β-D -glycero-pent-2-enofuranosyl)thymine;1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione;2′,3′-Anhydrothymidine
CAS NO.:3056-17-5
Empirical Formula: C10H12N2O4
Molecular Weight: 224.21
MDL number: MFCD00132921
EINECS: 641-374-0
Pack Size | Price | Stock | Quantity |
1G | RMB47.20 | In Stock |
|
5G | RMB87.20 | In Stock |
|
25G | RMB351.20 | In Stock |
|
100G | RMB1212.00 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 159-160°C |
alpha | D25 -39.4° (c = 0.701 in water); D20 -46.1° (c = 0.7 in water) |
Density | 1.374±0.06 g/cm3(Predicted) |
refractive index | -46 ° (C=0.69, H2O) |
storage temp. | -20°C |
solubility | Soluble in water, sparingly soluble in ethanol (96 per cent), slightly soluble in methylene chloride. It shows polymorphism (5.9). |
form | Solid |
pka | 9.47±0.10(Predicted) |
color | White |
Water Solubility | 5-10 g/100 mL at 21 ºC |
BCS Class | 1,3 |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
InChIKey | XNKLLVCARDGLGL-JGVFFNPUSA-N |
Description and Uses
Stavudine, a dideoxynucleoside analog of thymidine, has been introduced in the U.S.A. for the treatment of late-stage AIDS patients who are refractory to other AIDS treatments. Similar as other currently available agents for AIDS treatment such as zidovudine (AZT), didanosine, and zalcitabine, the anti-HIV activity of these 2'3'- dideoxynucleosides is ascribed to the inhibitory effect of their corresponding 5'- triphosphates against the HlVsncoded RNAdependent DNA polymerase (reverse transcriptase). While some of these drugs have rapid development of drug resistance, stavudine is active against AZT-resistant HIV strains. It has a favorable pharmacokinetic profile with more complete and less variable oral absorption than AZT and didanosine and has a bioavailability of 80-90%.
angiotensin 1 receptor antagonist